|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 2725028 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13197815.7 |
| Date of filing the European patent application | 2009-10-21 | |
| (97) | Date of publication of the European application | 2014-04-30 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
| (46) | Date of publication of the claims translation | 2016-09-26 |
| (30) | Number | Date | Country code |
| 107616 P | 2008-10-22 | US |
| (72) |
Haas, Julia, US
Andrews, Steven, W., US
Jiang, Yutong, US
Zhang, Gan, US
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Pakeistieji pirazolo[1,5-a]pirimidino junginiai kaip tarpiniai junginiai TRK kinasės slopiklių sintezėje |
| Substituted pyrazolo[1,5-]pyrimidine compounds as intermediates in the synthesis of TRK kinase inhibitors |
| Payment date | Validity (years) | Amount | |
| 2022-10-17 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-10-21 |